Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Helena R Chang"'
Autor:
Na Sun, Ceng Zhang, Yi‐Te Lee, Benjamin V. Tran, Jing Wang, Hyoyong Kim, Junseok Lee, Ryan Y. Zhang, Jasmine J. Wang, Junhui Hu, Zhicheng Zhang, Manaf S. Alsudaney, Kuan‐Chu Hou, Hubert Tang, Tiffany X. Zhang, Icy Y. Liang, Ziang Zhou, Mengxiang Chen, Angela Hsiao‐Jiun Yeh, Wenyuan Li, Xianghong Jasmine Zhou, Helena R. Chang, Steven‐Huy B. Han, Saeed Sadeghi, Richard S. Finn, Sammy Saab, Ronald W. Busuttil, Mazen Noureddin, Walid S. Ayoub, Alexander Kuo, Vinay Sundaram, Buraq Al‐Ghaieb, Juvelyn Palomique, Kambiz Kosari, Irene K. Kim, Tsuyoshi Todo, Nicholas N. Nissen, Maria Lauda Tomasi, Sungyong You, Edwin M. Posadas, James X. Wu, Madhuri Wadehra, Myung‐Shin Sim, Yunfeng Li, Hanlin L. Wang, Samuel W. French, Shelly C. Lu, Lily Wu, Renjun Pei, Li Liang, Ju Dong Yang, Vatche G. Agopian, Hsian‐Rong Tseng, Yazhen Zhu
Publikováno v:
Hepatology. 77:774-788
The sensitivity of current surveillance methods for detecting early-stage hepatocellular carcinoma (HCC) is suboptimal. Extracellular vesicles (EVs) are promising circulating biomarkers for early cancer detection. In this study, we aim to develop an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba65effbecbbd94cfd6340364de74ed3
https://doi.org/10.1002/hep.32692
https://doi.org/10.1002/hep.32692
Autor:
Helena R. Chang, Shivani Sharma, Jianyu Rao, Michael LeClaire, James A. Wohlschlegel, James K. Gimzewski, Madhuri Wadehra, Weibo Yu, David Elashoff
Publikováno v:
ACS Applied Nano Materials. 4:9876-9885
Breast cancer cells secrete abundant nanometer-sized vesicles. Small extracellular vesicle (or sEV) cargos are known to have similar biomolecular signatures to their secreting parental breast cance...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54aaf4220cfb98c53cff8f5e54a5b538
https://doi.org/10.1021/acsanm.1c02299
https://doi.org/10.1021/acsanm.1c02299
Publikováno v:
Cancer Research. 80:P1-20
Introduction Delayed breast cancer surgery, especially in those with aggressive subtypes of breast cancer, is always a great concern but not an infrequent occurrence. This study aimed to determine how frequently this occurs and its impact on overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7777c18bf18ffe6a35f36ecc79f5ca95
https://doi.org/10.1158/1538-7445.sabcs19-p1-20-13
https://doi.org/10.1158/1538-7445.sabcs19-p1-20-13
Autor:
Jane M Wei, Paul Kim, Cheryl Ewing, Jasmine Wong, Laura J Esserman, Michael D Alvarado, Abimbola O Olusanya, Skye Stewart, Ashley Tydon, Parima Daroui, Jeffrey V Kuo, Hannah L Park, Karen T Lane, Eliza Jeong, Kelsey Brown, Ava Hosseini, Barbara A Parker, Sarah L Blair, Athena Breast Health Network Investigators, Frederick Baehner, Olivier Harismendy, Antonia Petruse, Carlie K Thompson, Helena R Chang, Alexander D Borowsky, Christina Yau, Gillian L Hirst, Richard J Bold, Rita A Mukhtar
Publikováno v:
Cancer Research. 80:OT3-09
Background: Ductal carcinoma in situ (DCIS) now represents nearly a quarter of newly diagnosed breast cancers in the United States. Standard-of-care treatment for DCIS is aggressive local therapy consisting of either mastectomy or breast conserving s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c2533d50b993a1cac22f32742ed205a
https://doi.org/10.1158/1538-7445.sabcs19-ot3-09-01
https://doi.org/10.1158/1538-7445.sabcs19-ot3-09-01
Publikováno v:
Cancer Research. 80:P2-18
Introduction: It is always a great concern when breast cancer treatment is delayed for a variety of reasons such as patient personal situation, medical conditions, insurance issues and scheduling difficulties. Most studies regarding delayed cancer tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ae6ec7a9d73b641750998087b80b6af
https://doi.org/10.1158/1538-7445.sabcs19-p2-18-05
https://doi.org/10.1158/1538-7445.sabcs19-p2-18-05
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 2011, Iss 5, Pp 175-199 (2011)
Externí odkaz:
https://doaj.org/article/1a283a2e1d2c47acbc6147b382cd481b
Autor:
Ming Lu, Kym F. Faull, Julian P. Whitelegge, Jianbo He, Dejun Shen, Romaine E. Saxton, Helena R. Chang
Publikováno v:
Biomarker Insights, Vol 2, Pp 347-360 (2007)
Proteomics is a rapidly advancing field not only in the field of biology but also in translational cancer research. In recent years, mass spectrometry and associated technologies have been explored to identify proteins or a set of proteins specific t
Externí odkaz:
https://doaj.org/article/6a9160ff5ad34c79be24167e5a1ba36c
Publikováno v:
Carcinogenesis, vol 39, iss 7
Increasingly affordable high-throughput molecular profiling technologies have made feasible the measurement of omics-wide interindividual variations for the purposes of predicting cancer prognosis. While multiple types of genetic, epigenetic and expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a6176a16a0f402e9479ff8443f9eb8
https://doi.org/10.1093/carcin/bgy055
https://doi.org/10.1093/carcin/bgy055
Autor:
Mary-Lynn Brecht, Diana C. Márquez-Garbán, Michael E. Jung, David Elashoff, Neda A. Moatamed, Richard J. Pietras, Helena R. Chang, Begonya Comin-Anduix, Yahya Elshimali, Adrienne Martinez, Isabel Jabara, Jaydutt V. Vadgama, David Austin, Lorena P. Burton, Tristan Grogan, Nalo Hamilton, Madhuri Wadehra
Publikováno v:
Cancer Research. 81:943-943
Triple-negative breast cancer (TNBC) affects only about 10-15% of women with breast cancer (BC) but accounts for almost 50% of all BC deaths. At this time, development of targeted treatments for TNBC are urgently needed. Insulin-like growth factor-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe313d38b00e8dc04a084ed351b99ab5
https://doi.org/10.1158/1538-7445.am2021-943
https://doi.org/10.1158/1538-7445.am2021-943
Autor:
William Y. Luo, Helena R. Chang, Hong Zhao, Sophia K. Apple, Jeongyoon Song, Minna Lee, Debra U. Chung, Richard J. Pietras, Xinyu Deng, Xiancheng Wu
Publikováno v:
Oncotarget
Oncotarget, vol 8, iss 24
Oncotarget, vol 8, iss 24
Breast cancer (BC) is a leading cause of cancer-related death in women. Adjuvant systemic chemotherapies are effective in reducing risks of recurrence and have contributed to reduced BC mortality. Although targeted adjuvant treatments determined by b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb49fcb558313235da2c224cd7092b5a
http://europepmc.org/articles/PMC5503533
http://europepmc.org/articles/PMC5503533